Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management

European Journal of Clinical Investigation

Volumn 30, Issue 3, 2000, Pages 239-247

  Brito, M A ^a   Silva, R ^a   Tiribelli, C ^b   Brites, Dora ^a,c  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF TRIESTE   (Italy)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Bilirubin cytotoxicity; Crenation; Erythrocyte bound bilirubin; Haemolysis; Lipid elution; Unbound bilirubin

Indexed keywords

ALBUMIN; BILIRUBIN; CHLOROFORM; MEMBRANE LIPID;

ARTICLE; CYTOTOXICITY; DISEASE COURSE; ECHINOCYTE; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; NEWBORN JAUNDICE; PRIORITY JOURNAL;

BILIRUBIN; CHLOROFORM; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; LIPID METABOLISM; PROTEIN BINDING; SERUM ALBUMIN;

EID: 0034015283     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00612.x     Document Type: Article

References (70)

1. 1 Hsia DY-Y, Allen FH, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. New Engl J Med 1952;247:668-71.
2. 2 Cashore WJ. Hyperbilirubinemia: should we adopt a new standard of care? Pediatrics 1992;89:824-6.
3. 3 Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994;93:488-94.
4. 4 Bratlid D. Bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 1972;29:91-7.
5. 5 Brodersen R. Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr Scand 1977;66:625-34.
6. 6 Brodersen R. Binding of bilirubin to albumin. Crit Rev Clin Lab Sci 1979;11:305-401.
7. 7 Hansen TW, Bratlid D. Bilirubin and brain toxicity. Acta Paediatr Scand 1986;75:513-22.
8. 8 Brites D. Bilirrubina: Contribuição para o escudo do mecanismo da sua acção tóxica com particular relevância para o período neonatal precoce. Dissertation. Portugal: Lisbon University; 1988.
9. 9 Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992;89:809-18.
10. 10 Gourley GR. Bilirubin metabolism and kernicterus. Adv Pediatr 1997;44:173-229.
11. 11 Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14.
12. 12 Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 1998;25:555-74.
13. 13 Watson D. The absorption of bilirubin by erythrocytes. Clin Chim Acta 1962;7:733-4.
14. 14 Bratlid D. The effect of pH on bilirubin binding by human erythrocytes. Scand J Clin Lab Invest 1972;29:453-9.
15. 15 Kaul R, Bajpai UK, Shipstone AC, Kaul AH, Mutri CRK. Bilirubin-induced erythrocyte membrane cytotoxicity. Exp Mol Pathol 1981;34:290-8.
16. 16 Kirschner-Zilber I, Rabizadeh E, Shaklai N. The interaction of hemin and bilirubin with human red cell membrane. Biochim Biophys Acta 1982;690:20-30.
17. 17 Wennberg RP. The importance of free bilirubin acid salt in bilirubin uptake by erythrocytes and mitochondria. Pediatr Res 1988;23:443-7.
18. 18 Brito MA, Silva RM, Matos DC, da Silva AT, Brites DT. Alterations of erythrocyte morphology and lipid composition by hyperbilirubinemia. Clin Chim Acta 1996;249:149-65.
19. 19 Brites D, Silva R, Brito A. Effect of bilirubin on erythrocyte shape and haemolysis, under hypotonic, aggregating or non-aggregating conditions, and correlation with cell age. Scand J Clin Lab Invest 1997;57:337-50.
20. 20 Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res 1999;45:355-62.
21. 21 Sato H, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Biochem J 1983;210:489-96.
22. 22 Chen LX, Lu JF, Wang K. The influence of bilirubin on fluidity and rotational correlation times of human erythrocyte membrane. Cell Biol Inter Rep 1992;16:567-73.
23. 23 Sato H, Aono S, Semba R, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Bilirubin binding to neuraminidase-and phospholipase-treated membranes. Biochem J 1987;248:21-6.
24. 24 Brodersen R. Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem 1979;254:2364-9.
25. 25 Eriksen EF, Danielsen H, Brodersen R. Bilirubin-liposome interaction. Binding of bilirubin dianion, protonization, and aggregation of bilirubin acid. J Biol Chem 1981;256:4269-74.
26. 26 Leipe S. Bilirubin-induced cytomorphological changes in guinea-pig leucocytes. Biomed Biochim Acta 1983;42:503-10.
27. 27 McDonagh AF, Assisi F. The ready isomerization of bilirubin IX-α in aqueous solution. Biochem J 1972;129:797-800.
28. 28 Sen Gupta PC, Ghosal SP, Mukherjee AK, Maity TR. Bilirubin crystals in neutrophils of jaundiced neonates and infants. Acta Haematol 1983;70:69-70.
29. 29 Brodersen R, Stern L. Deposition of bilirubin acid in the central nervous system - a hypothesis for the development of kernicterus. Acta Paediatr Scand 1990;79:12-9.
30. 30 Ozmert E, Erdem G, Topcu M, Yurdakok M, Tekinalp G, Genc D, et al. Long-term follow-up of indirect hyperbilirubinaemia in full-term Turkish infants. Acta Paediatr 1996;85:1440-4.
31. 31 Perlman JM, Rogers BB. Kernicteric findings at autopsy in two sick near term infants. Pediatrics 1997;99:612-5.
32. 32 Darnell J, Lodish H, Baltimore D. Molecular Cell Biology. New York: Scientific American Books; 1990.
33. 33 Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell. New York: Garland Publishing; 1994.
34. 34 Hsu RC, Kanofsky JR, Yachnin S. The formation of echinocytes by the insertion of oxygenated sterol compounds into red cell membranes. Blood 1980;56:109-17.
35. 35 Fujii T, Sato T, Tamura A, Wakatsuki M, Kanaho Y. Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cells. Biochem Pharmacol 1979;28:613-20.
36. 36 Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem 1974;20: 783-9.
37. 37 Brodersen R, Cashore W, Wennberg RP, Ahlfors CE, Rasmussen LF, Shusterman D. Kinetics of bilirubin oxidation with peroxidase, as applied to studies of bilirubin-albumin binding. Scand J Clin Lab Invest 1979;39:143-50.
38. 38 Moreau-Clevede J, Pays M. Détermination de la bilirubine érythrocytaire. Ann Biol Clin 1979;37:95-101.
39. 39 Brites D, Silveira C, Pays M, Amaral JMV, Aparício O, Lobato MR, et al. Bilirrubina eritrocitária no período neonatal precoce. Estudo do seu comportamento em recém-nascidos com e sem risco de icterícia nuclear. Rev Port Pediat 1981;12:1-14.
40. 40 Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963;100:119-29.
41. 41 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
42. 42 McDonagh AF. Bile pigments: bilatrienes and 5,15 biladienes. In Dolphin D, editor. The Porphyrins. New York: Academic Press; 1979. p.294-491.
43. 43 Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-8.
44. 44 Ott P, Binggeli Y, Brodbeck URS. A rapid and sensitive assay for determination of cholesterol in membrane lipid extracts. Biochim Biophys Acta 1982;685:211-3.
45. 45 Poland RL. In search of a 'gold standard' for bilirubin toxicity. Pediatrics 1992;89:823-4.
46. 46 Jacobsen J. Binding of bilirubin to human serum albumin -determination of the dissociation constants. FEBS Lett 1969;5:112-4.
47. 47 Karp WB. Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review. Pediatrics 1979;64:361-8.
48. 48 Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642-7.
49. 49 Ihara H, Hashizume N, Shimizu N, Aoki T. Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler-Najjar syndrome. Ann Clin Biochem 1999;36:347-52.
50. 50 Jacobsen J. Studies of the affinity of human serum albumin for binding of bilirubin at different temperatures and ionic strength. Int J Peptide Protein Res 1977;9:235-9.
51. 51 Gray RD, Stroupe SD. Kinetics and mechanism of bilirubin binding to human serum albumin. J Biol Chem 1978;253:4370-3.
52. 52 Ostrow JD, Mukerjee P, Tiribelli C. Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res 1994;35:1715-37.
53. 53 Brodersen R. Physical chemistry of bilirubin: binding to macromolecules and membranes. In Heirwegh KPM, Brown SB, editors. Bilirubin Chemistry, Vol. 1. Florida: CRC Press; 1982. p.75-123.
54. 54 Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 1974;71:4457-61.
55. 55 Thimon L, Peypoux F, Exbrayat JM, Michel G. Effect of iturin A, a lipopeptide from Bacillus subtillis, on morphology and ultrastructure of human erythrocytes. Cytobios 1994;79:69-83.
56. 56 Latoud C, Peypoux F, Michel G, Genet R, Morgat JL. Interactions of antibiotics of the iturin group with human erythrocytes. Biochim Biophys Acta 1986;856:526-35.
57. 57 Bouillerot A, Fessard C, Sauger F. La bilirubine érythrocytaire: ses variations - interêt pratique de son dosage. Clin Chim Acta 1981;109:39-44.
58. 58 Barthez JP, Boisseau C, Bentata J, Borderon E. Étude de la bilirubine éryhtrocytaire. Appréciation du risque d'ictère nucléaire. Pathol Biol 1982;30:252-6.
59. 59 Malik GK, Goel GK, Vishwanathan PN, Misra PK, Sharma B. Free and erythrocyte-bound bilirubin in neonatal jaundice. Acta Paediatr Scand 1986;75:545-9.
60. 60 Kaufmann NA, Simcha AJ, Blondheim SH. The uptake of bilirubin by blood cells from plasma and its relationship to the criteria for exchange transfusion. Clin Sci 1967;33:201-8.
61. 61 Tayyab S, Rao SY. Evaluation of bilirubin displacing effect of indomethacin by determination of erythrocyte-bound bilirubin. Biochem Mol Biol Int 1995;36:499-504.
62. 62 Zakim D, Wong PTT. A high-pressure, infrared spectroscopic study of the solvation of bilirubin in lipid bilayers. Biochemistry 1990;29:2003-7.
63. 63 Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999;274:10852-62.
64. 64 Blondheim SH, Kapitulnik J, Valaes T, Kaufmann NA. Use of a Sephadex column to evaluate the bilirubin-binding capacity of the serum of infants with neonatal jaundice. Isr J Med Sci 1972;8:22-7.
65. 65 Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96:730-3.
66. 66 Oygur N, Nuzumlali D, Ersay A, Velipasaoglu S, Yegin O. Bilirubin toxicity: outcome in infants with high bilirubin levels. Eur J Pediatr 1996:155:145-6.
67. 67 Hansen TW. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997;86:843-6.
68. 68 Vazquez J, Garcia-Calvo M, Valdivieso F, Mayor F, Mayor F Jr. Interaction of bilirubin with the synaptosomal plasma membrane. J Biol Chem 1988;263:1255-65.
69. 69 Tayyab S, Ali MK. A comparative study on the extraction of membrane-bound bilirubin from erythrocyte membranes using various methods. J Biochem Biophys Methods 1999;39:39-45.
70. 70 Ritter DA, Kenny JD, Norton HJ, Rudolph AJ. A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics 1982;69:260-6.